Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Tuberculosis Vaccines
Study results from M. Domingo and colleagues broaden understanding of tuberculosis vaccines
June 3rd, 2009
Data detailed in 'Effectiveness and safety of a treatment regimen based on isoniazid plus vaccination with Mycobacterium tuberculosis cells' fragments: field-study with naturally Mycobacterium caprae-infected goats' have been presented. "The identification of a herd of goats with tuberculosis let us test a new treatment regimen against latent tuberculosis infection (LTBI). Using large animal experimental models allows a better approach to understanding human tuberculosis according to immunopathological parameters," investigators in Spain report. "Based on an initial study showing a correlation between the ESAT-6-specific interferon (IFN)-gamma secretion and the severity...
Source: Vaccine Weekly (2009-06-03)
|
